News

An agency reshaped for the future. The European Medicines Agency (EMA) has announced details of its new organizational structure.

The Omnibus Final Rule (Final Rule) entitled "Modifications of the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the HITECH Act" became effective on March 26, 2013.

As clinical researchers, it?s natural for us to think of patients first and foremost as research participants (potential or current). But that?s not how patients think of themselves.

The Omnibus Final Rule (Final Rule) entitled "Modifications of the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the HITECH Act" became effective on March 26, 2013.

Theorem Clinical Research has announced the formation of a strategic alliance with Charles River Laboratories that will provide clients with an integrated solution from nonclinical testing and analysis through clinical development and registration.

While lack of commercial viability is the leading cause of Phase I failures for new drug candidates, efficacy issues dominate as the reason for Phase II failures, according to a new analysis from the Tufts Center for the Study of Drug Development.

Intralinks? Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, and IRB Services? (Institutional Review Board Services), a leading, global provider of research ethics review and related services for the clinical research and behavioral science industries, striving for excellence in human research participant protection, today announced that the IRB Services team has selected Intralinks VIA? to support all of its secure beyond the firewall collaboration needs.

To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat?Tech Services, LLC ? a Contract Research Organization (CRO) with extensive experience in the medical devices sector.

Almac today announced they are now offering a Tumor Profiling service running Illumina?s next-generation sequencing (NGS) TruSight Tumor? panel as part of their biomarker discovery, development and delivery solutions.

CTI Clinical Trial and Consulting Services (CTI) announces that it has opened an office in Milan, Italy. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services Italy, S.R.L.

The process of bringing a new molecular entity or device to market has historically been long, costly and both paper and people intensive.

Externally validated program sets global standard for measuring competence of clinical monitors

The International Academy of Clinical Research (IAoCR) welcomes the news today from the Nursing and Midwifery Council that it is introducing three-yearly checks for nurses and midwifes from the end of 2015 to ensure they are fit to practice.

Theorem Clinical Research has announced the addition of Ximedica, a medical product development firm, to its roster of strategic alliances.

CenterWatch, a leading publisher of clinical trials information for patients and professionals, announced today that it has launched a revamped version of its award-winning Clinical Trials Listing Service (CTLS) to better serve the public and patient communities.

Combined technology solution evaluates study data within the EDC system against contract criteria and generates financial transactions and all related accounting information

Kenneth Kirby, the president of TransDermal Delivery Solutions Corp., sees his company?s transdermal drug delivery system as transforming the way we think about medication.

Alliance increases focus on bringing more clinical research to Indiana and provides quicker access to patients for complex Phase I clinical trials

Clinical research is complicated, and it?s not just the science. Take CDASH, CDISC and E2B for example. Aren?t acronyms awesome?

ACT December 2012 BPA Statement

Parexel's President & COO Mark Goldberg sat down with Applied Clinical Trials for a quick discussion on the trials market in Asia Pacific.

Industry news focusing on the people and organizations who work in the clinical trials profession.

S

There are signs of trouble in the latest announcement of user fees for 2014 authorized by the Prescription Drug User Fee Act (PDUFA).

We can simultaneously establish a database that identifies signals of risk for specific product classes, and also demonstrate products that might in fact reduce risk of suicidal ideation and behavior.

S

Industry news focusing on the people and organizations who work in the clinical trials profession.

Tufts CSDD